Bevacizumab and dyspnoea Patient Reports February 10, 2012

Bevacizumab Side Effects Report #4939161-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 09, 2006. Female patient, 53 years of age, weighting 127.0 lb, was diagnosed with rectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, ejection fraction decreased, hypoxia, lung disorder, oxygen saturation decreased, pulmonary oedema, ventricular hypokinesia. Bevacizumab dosage: unknown. During the same period patient was treated with FOLFOX. Patient recovered.

Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.

Bevacizumab Side Effects Report #6023686-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2008. Male patient, 73 years of age, weighting 180.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease, pneumonia , pneumonitis, productive cough, pulmonary toxicity. Bevacizumab dosage: 835MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient died on 12/19/2008.

Bevacizumab Side Effects Report #6025687-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2008. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma metastatic, dyspnoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: 835 MG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, STEROIDS, OXYGEN. Patient was hospitalized. Patient died on 12/19/2008.


Bevacizumab Side Effects Report #6044186-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2009. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma metastatic, dyspnoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, respiratory failure. Bevacizumab dosage: 835 MG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, STEROIDS, OXYGEN. Patient was hospitalized. Patient died on 12/19/2008.

Bevacizumab Side Effects Report #6062904-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 02, 2009. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma metastatic, dyspnoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, respiratory failure. Bevacizumab dosage: 835 MG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, STEROIDS, OXYGEN. Patient was hospitalized. Patient died on 12/19/2008.

Bevacizumab Side Effects Report #6011680-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2008. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decubitus ulcer, deep vein thrombosis , dyspnoea, oedema peripheral, pleural effusion, pulmonary embolism , white blood cell count decreased. Bevacizumab dosage: 1010MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5960281-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 18, 2008. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration pleural cavity abnormal, atelectasis, dyspnoea, inflammation, pleural effusion, pneumonia . Bevacizumab dosage: 630MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL, LOVAQUIN. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5802385-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 24, 2008. Female patient, 60 years of age, was diagnosed with pancreatic carcinoma metastatic, anal abscess and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, malignant hypertension. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, AMOXICILLIN AND CLAVULANATE POTASSIUM, MICROPIRIN, INSULIN, LIPIDAL, LEVEMIR, ACTRAPID. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6013467-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 18, 2008. Female patient, 58 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, bacteria urine, chest discomfort, chills, dyspnoea, hypotension, liver abscess, obstruction gastric, sepsis . Bevacizumab dosage: 740MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #6043516-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Female patient, 58 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, bacteria urine identified, chest discomfort, chills, device malfunction, dyspnoea, fungal infection , hypophagia, hypotension. Bevacizumab dosage: 740MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5616673-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2008. Female patient, 56 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, fall , pleural effusion. Bevacizumab dosage: 630 MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5963766-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2008. Female patient, 56 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, fall , pleural effusion. Bevacizumab dosage: 630MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5965615-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 17, 2008. Female patient, 56 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, fall , pleural effusion. Bevacizumab dosage: 630 MG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5981812-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 28, 2008. Female patient, 56 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, fall , pleural effusion. Bevacizumab dosage: 630 MG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5208959-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2007. Female patient, 62 years of age, weighting 94.00 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, infection , lung neoplasm, metastases to lung, pain , pulmonary embolism . Bevacizumab dosage: 446.00 MG Q 2 WEEKS IV. Patient was hospitalized. Patient died on 08/28/2006.

Bevacizumab Side Effects Report #4981907-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2006. Male patient, weighting 420.2 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood sodium decreased, chest pain , dyspnoea. Bevacizumab dosage: 15MG/KG Q 21-DAYS IV DRIP. During the same period patient was treated with ERLOTINIB, IBUPROFEN, PROTONIX, REGLAN, CLEOCIN T. Patient recovered.

Bevacizumab Side Effects Report #5856148-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 11, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, sinus tachycardia. Bevacizumab dosage: 480 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, ONDANSETRON, DIMETINDEN, RANITIDINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5912885-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, sinus tachycardia. Bevacizumab dosage: 480 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, ONDANSETRON, DIMETINDEN, RANITIDINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5949168-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea. Bevacizumab dosage: 623 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LERCANIDIPINE. Patient was hospitalized. Patient died on 10/13/2008.

Bevacizumab Side Effects Report #5953341-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, sinus tachycardia. Bevacizumab dosage: 480 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, ONDANSETRON, DIMETINDEN, RANITIDINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5483688-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea haemorrhagic, disease progression, dyspnoea, hypotension, small intestinal obstruction, west nile viral infection. Bevacizumab dosage: 10 MG QCD1 IV. During the same period patient was treated with CISPLATIN, DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5608791-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depressed level of consciousness, disease progression, dyspnoea, encephalopathy, hypotension, small intestinal obstruction, virus serology test positive. Bevacizumab dosage: 10 MG QCD1 AND8 IV. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5892936-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2008. Male patient, 58 years of age, weighting 181.0 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #4877502-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2006. Female patient, 62 years of age, weighting 985.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease recurrence, dyspnoea, malignant pleural effusion. Bevacizumab dosage: 15 MG/KG/ 660 Q 21 DA IV. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5383044-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Male patient, weighting 212.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, OMEPRAZOLE, NIFEDIPINE, LOVASTATIN, CLONIDINE, ATENOLOL, ACTOS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5394126-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Male patient, weighting 212.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, OMEPRAZOLE, NIFEDIPINE, LOVASTATIN, CLONIDINE, ATENOLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5606811-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 15, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, tachycardia. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, CORDARONE, HYPERIUM, EURELIX, KARDEGIC, ZOCOR, LEXOMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5606921-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 22, 2008. Male patient, weighting 181.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ALIMTA, GEMZAR. Patient died on 01/21/2008.


Bevacizumab Side Effects Report #5633085-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 06, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, tachycardia. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, CORDARONE, HYPERIUM, EURELIX, KARDEGIC, ZOCOR, LEXOMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5665116-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 07, 2008. Male patient, weighting 181.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ALIMTA, GEMZAR, AMBIEN, COMPAZINE, LEXAPRO, MEGACE, OXYGEN, PREDNISONE. Patient died on 01/21/2008.

Bevacizumab Side Effects Report #5761732-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 26, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, tachycardia. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, CORDARONE, HYPERIUM, EURELIX, ASPIRIN, ZOCOR, LEXOMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5847174-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, haemoglobin decreased, hypoxia, pneumonitis. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6009214-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 28, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pericardial effusion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient died on 08/24/2006.


Bevacizumab Side Effects Report #4796678-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Oct 06, 2005. Male patient, 48 years of age, weighting 216.5 lb, was diagnosed with neuroendocrine tumour and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, nausea . Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4993515-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Female patient, weighting 169.1 lb, was diagnosed with neuroendocrine tumour, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , aortic thrombosis, back pain , blood pressure increased, chest pain , dyspnoea, vomiting. Bevacizumab dosage: 375 MG QS Q 2 WEEKS IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5825769-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 28, 2008. Male patient, weighting 155.0 lb, was diagnosed with mucopolysaccharidosis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, ejection fraction decreased, hyperhidrosis, left ventricular dysfunction. Bevacizumab dosage: 1050MG IV Q 3 WEEKS. Patient recovered.

Bevacizumab Side Effects Report #5951660-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: 570 MG, UNK. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5642783-9
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Feb 27, 2008. Male patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature decreased, burning sensation, dyspnoea, erythema, flushing, heart rate decreased, infusion related reaction, oxygen saturation decreased. Bevacizumab dosage: 1425MG OTHER IV. Patient recovered.


Bevacizumab Side Effects Report #4699481-8
Bevacizumab side effect was reported by a Physician from on June 23, 2005. Female patient, 52 years of age, weighting 262.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, confusional state, dyspnoea, lung infiltration, productive cough, pyrexia, sputum discoloured, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4705470-7
Bevacizumab side effect was reported by a Physician from on June 30, 2005. Female patient, 52 years of age, weighting 202.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, confusional state, dyspnoea, productive cough, pyrexia, respiratory failure, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient died on 06/29/2005.

Bevacizumab Side Effects Report #5969360-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2008. Male patient, weighting 201.0 lb, was diagnosed with head and neck cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, AVALIDE, ANDROGEL, TRAZODONE, CYMBALTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6023988-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 23, 2008. Male patient, weighting 201.0 lb, was diagnosed with head and neck cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, AVALIDE, ANDROGEL, TRAZODONE, CYMBALTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5311623-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, alopecia, asthenia, blood glucose increased, crying, dyspnoea, oedema, pneumonitis. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, DEXAMETHASONE, LUNESTA, TYLENOL, POTASSIUM ACETATE, LASIX, VYTORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5685157-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 13, 2008. Female patient was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, head injury. Bevacizumab dosage: 650 MG, Q2W. During the same period patient was treated with CETUXIMAB. Patient died on 01/21/2008.

Bevacizumab Side Effects Report #5938193-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 16, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonia . Bevacizumab dosage: 430 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, OMNIC, LANSOPRAZOLE. Patient was hospitalized. Patient died on 10/13/2008.

Bevacizumab Side Effects Report #5847289-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Female patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dyspnoea, mucosal inflammation. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5987749-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 24, 2008. Male patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: 510 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, SIMVASTATIN. Patient died on 11/19/2008.

Bevacizumab Side Effects Report #4614898-5
Bevacizumab side effect was reported by a Pharmacist from on Mar 18, 2005. Male patient, 59 years of age, weighting 179.7 lb, was diagnosed with colon cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea. Bevacizumab dosage: 400MG, INFUSE O, INTRAVEN. Patient recovered.


Bevacizumab Side Effects Report #5315565-5
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Apr 30, 2007. Male patient, 85 years of age, weighting 193.6 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, diarrhoea, dyspnoea, hypotension, ileus, malaise, myocardial infarction, nausea , pneumatosis. Bevacizumab dosage: 700 MG ONCE IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5261994-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, 71 years of age, weighting 172.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, thrombosis in device, tracheitis. Bevacizumab dosage: 5MG/KG Q2W IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LIPITOR, NIASPAN, QUANAPRIL, COREG, HEMOCYTE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5266786-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, 71 years of age, weighting 172.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, impaired healing, respiratory tract irritation, tracheal haemorrhage. Bevacizumab dosage: 5MG/KG Q2W IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LIPITOR, NIASPAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5288013-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, 71 years of age, weighting 172.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anastomotic complication, dyspnoea, procedural site reaction, respiratory tract irritation, thrombosis, tracheal disorder. Bevacizumab dosage: 5MG/KG Q2W IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LIPITOR, NIASPAN, QUANAPRIL, COREG, HEMOCYTE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5215801-X
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 08, 2007. Female patient, 54 years of age, weighting 140.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , atelectasis, blood bilirubin increased, cardiac arrest , diarrhoea, dyspnoea, hepatic necrosis, hepatic steatosis, intestinal ischaemia. Bevacizumab dosage: 640 MG, Q3W, INTRAVENOUS. During the same period patient was treated with XELODA, DARVOCET, PHENERGAN, PROPOFOL. Patient was hospitalized. Patient died on 11/30/2006.

Bevacizumab Side Effects Report #5246603-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2007. Female patient, weighting 141.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, jaundice , metastases to liver, pain , peritoneal carcinoma. Bevacizumab dosage: 5MG/KG Q 2 WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5961897-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 05, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, hypoaesthesia, myocardial infarction. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient recovered.

Bevacizumab Side Effects Report #6019656-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 11, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cytotoxic cardiomyopathy, dyspnoea, hypoaesthesia. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, FOLINIC ACID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4934938-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 73 years of age, weighting 141.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bacteraemia, dehydration, dyspnoea, hypokalaemia, international normalised ratio increased, pulmonary embolism , renal failure acute, staphylococcal infection . Bevacizumab dosage: 5 MG/KG DAY 1 IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, ERLOTINIB, ACTOS, COMPAZINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5450421-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient, 66 years of age, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, hypoxia, myocardial ischaemia. Bevacizumab dosage: 695 MG, Q2W. During the same period patient was treated with EVEROLIMUS, TOPROL, COUMADIN, ZETIA, NORVASC, VITAMIN B6, FISH OIL, STOOL SOFTENER. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5828353-8
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on July 29, 2008. Male patient, 57 years of age, weighting 273.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, hypoaesthesia, muscle spasms, neuropathy peripheral. Bevacizumab dosage: 600 MG ONCE IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5599719-9
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 18, 2008. Female patient, 29 years of age, weighting 140.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pharyngolaryngeal discomfort, urticaria. Bevacizumab dosage: 314 MG (1ST DOSE IV). During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, CIMETIDINE, DIPHENHYDRAMINE, DEXAMETHASONE, OXALIPLATIN. Patient recovered.

Bevacizumab Side Effects Report #5529688-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 15, 2007. Male patient, weighting 180.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, endocarditis , tachycardia. Bevacizumab dosage: 400 MG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, FUSIDATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5218715-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2007. Female patient, 71 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aldolase increased, antinuclear antibody positive, arthritis , blood glucose increased, blood immunoglobulin g increased, decreased appetite, dyspnoea, glycosylated haemoglobin increased, haemoglobin decreased. Bevacizumab dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, METFORMIN, NPH INSULIN, PROPACET, SENNOSIDE A. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5178847-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2006. Female patient, 71 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: angiopathy, arthralgia, chest x-ray abnormal, cough, dyspnoea, dysuria, flatulence, mental status changes, myalgia. Bevacizumab dosage: 700 MG, UNK, INTRAVENOUS. During the same period patient was treated with PERCOCET, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5179290-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2006. Female patient, 71 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthritis , c-reactive protein increased, dyspnoea, glycosylated haemoglobin increased, oedema peripheral, pain in extremity, pain in jaw, pyrexia. Bevacizumab dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with METFORMIN, PROPACET, SENNOSIDE A. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5391543-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 04, 2007. Female patient, weighting 139.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, hypertension, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5418292-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2007. Female patient, weighting 139.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, hypertension, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5450439-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 29, 2007. Female patient, weighting 139.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, hypertensive crisis, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5523771-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 09, 2007. Female patient, weighting 139.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, hypertensive crisis, pneumonitis. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.


Bevacizumab Side Effects Report #5624655-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 29, 2008. Female patient, weighting 135.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, hypertensive crisis, pneumonitis, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5752332-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 14, 2008. Female patient, weighting 135.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, hypertensive crisis, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5917976-3
Bevacizumab side effect was reported by a Physician from JAPAN on Sept 29, 2008. Female patient was diagnosed with breast cancer metastatic, insomnia, diabetes mellitus, pain , dyspepsia, cough, constipation  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, malaise, vocal cord paralysis. Bevacizumab dosage: 565 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, RILMAZAFONE HYDROCHLORIDE, GLIMEPIRIDE, LOXOPROFEN, REBAMIPIDE, CARBOCISTEINE, BRIPLATIN, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5987402-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 03, 2008. Female patient, weighting 200.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , dyspnoea. Bevacizumab dosage: 925 MG, Q3W. During the same period patient was treated with ARIMIDEX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6022206-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 17, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aortic stenosis, cardiac failure, dyspnoea, pulmonary oedema. Bevacizumab dosage: 550 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, FUROSEMIDE, ONDANSETRON, DOMPERIDONE, RAMIPRIL, DIFFLAM, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6029163-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 29, 2008. Female patient, weighting 200.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , dyspnoea. Bevacizumab dosage: 925 MG, Q3W. During the same period patient was treated with ARIMIDEX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6104205-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2009. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5297519-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, 61 years of age, weighting 131.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea. Bevacizumab dosage: 620 MG, Q2W. During the same period patient was treated with PACLITAXEL, ATIVAN, COMPAZINE, NEULASTA, ARANESP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5316717-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2007. Female patient, 61 years of age, weighting 131.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea. Bevacizumab dosage: 620 MG, Q2W. During the same period patient was treated with PACLITAXEL, ATIVAN, COMPAZINE, NEULASTA, ARANESP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5884894-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 15, 2008. Female patient, 46 years of age, weighting 154.1 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure, dyspnoea, fatigue, malaise, nausea , productive cough. Bevacizumab dosage: 15MG/KG IV Q 3 WEEKS. During the same period patient was treated with CAPECITABINE, ATIVAN, EFFEXOR. Patient was hospitalized. Patient died on 09/04/2008.


Bevacizumab Side Effects Report #5299706-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2007. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Bevacizumab dosage: 15 MG/M2, Q2W. During the same period patient was treated with ARIMIDEX, COLACE, MOTRIN IB, LEVOXYL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5531814-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2007. Female patient, weighting 147.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood pressure immeasurable, c-reactive protein increased, cardiac arrest , cardiac disorder, cardiac enzymes increased, cerebral artery embolism, dyspnoea, left ventricular dysfunction. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient died on 09/23/2007.

Bevacizumab Side Effects Report #5547342-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, sepsis , ulcer . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5547348-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, blood culture positive, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, perineal abscess, sepsis . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5554544-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2007. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, disease progression, dyspnoea, left ventricular failure, myocardial ischaemia, pleural effusion. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5847145-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, dizziness , dyspnoea, fatigue, headache , hypokalaemia, lethargy. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5887024-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, hyperglycaemia. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with VORINOSTAT, TAXOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5934825-8
Bevacizumab side effect was reported by a Physician from JAPAN on Oct 14, 2008. Female patient was diagnosed with breast cancer , insomnia, diabetes mellitus, pain , dyspepsia, cough, constipation  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cataract , disease progression, dyspnoea, malaise, vocal cord paralysis. Bevacizumab dosage: 565 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, RILMAZAFONE HYDROCHLORIDE, GLIMEPIRIDE, LOXOPROFEN, REBAMIPIDE, CARBOCISTEINE, BRIPLATIN, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5958781-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, hyperglycaemia, thrombosis. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with VORINOSTAT, TAXOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5976444-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 07, 2008. Male patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Bevacizumab dosage: 550 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, FUROSEMIDE, ONDANSETRON, DOMPERIDONE, RAMIPRIL, DIFFLAM, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5985208-6
Bevacizumab side effect was reported by a Physician from JAPAN on Oct 14, 2008. Female patient was diagnosed with breast cancer , insomnia, diabetes mellitus, pain , dyspepsia, cough, constipation  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, malaise, vocal cord paralysis. Bevacizumab dosage: 565 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, RILMAZAFONE HYDROCHLORIDE, GLIMEPIRIDE, LOXOPROFEN, REBAMIPIDE, CARBOCISTEINE, BRIPLATIN, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6002013-5
Bevacizumab side effect was reported by a Physician from JAPAN on Dec 01, 2008. Female patient was diagnosed with breast cancer , insomnia, diabetes mellitus, pain , dyspepsia, cough, constipation  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, malaise, vocal cord paralysis. Bevacizumab dosage: 565 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, RILMAZAFONE HYDROCHLORIDE, GLIMEPIRIDE, LOXOPROFEN, REBAMIPIDE, CARBOCISTEINE, BRIPLATIN, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6006444-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 02, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aortic stenosis, dyspnoea. Bevacizumab dosage: 550 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, FUROSEMIDE, ONDANSETRON, DOMPERIDONE, RAMIPRIL, DIFFLAM, LEVOTHYROXINE. Patient recovered.

Bevacizumab Side Effects Report #6012627-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, neuropathy peripheral, supraventricular tachycardia. Bevacizumab dosage: 10 MG/KG, Q14D. During the same period patient was treated with PACLITAXEL. Patient recovered.

Bevacizumab Side Effects Report #6012671-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aortic stenosis, cardiac failure, dyspnoea, pulmonary oedema. Bevacizumab dosage: 550 MG, 2/WEEK. During the same period patient was treated with PACLITAXEL, FUROSEMIDE, ONDANSETRON, DOMPERIDONE, RAMIPRIL, DIFFLAM, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5344168-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Male patient, weighting 177.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea, gastrointestinal disorder, hiccups, large intestine perforation, nausea , pneumoperitoneum. Bevacizumab dosage: 402 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5354495-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, weighting 166.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: unknown. During the same period patient was treated with PANITUMUMAB, OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient died on 10/15/2006.

Bevacizumab Side Effects Report #5354712-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, weighting 166.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: unknown. During the same period patient was treated with PANITUMUMAB, OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient died on 10/15/2006.

Bevacizumab Side Effects Report #5368850-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 21, 2007. Male patient, weighting 181.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, dysphagia, dyspnoea, respiratory distress, tracheal disorder. Bevacizumab dosage: 823 MG EVERY OTHER WEEK IV DRIP. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5676673-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2008. Female patient, weighting 168.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, abscess , cholestasis, computerised tomogram abnormal, dyspnoea, hyperbilirubinaemia, hyponatraemia, ill-defined disorder, jaundice . Bevacizumab dosage: 390 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/16/2008.

Bevacizumab Side Effects Report #5742361-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2008. Female patient, weighting 200.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dizziness , dyspnoea, headache , hypertension. Bevacizumab dosage: 439 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5749692-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2008. Female patient, weighting 200.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , dizziness , dyspnoea, headache , hypertension. Bevacizumab dosage: 439 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5957367-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Male patient was diagnosed with small cell lung cancer extensive stage and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, infection . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CISPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/08/2005.